310 results on '"Natanson C"'
Search Results
2. Endotoxin in Septic Shock
3. The Role of Endotoxin in Bacterial Septic Shock
4. Human and Canine Septic Shock: Studies of Cardiovascular Abnormality, Mediators, and Therapies
5. Transfusion of fresh vs. older red blood cells in the context of infection
6. Increasing the Efficacy of Anti-Inflammatory Agents Used in the Treatment of Sepsis
7. Information Assurance
8. Cell-Free Hemoglobin Challenge Worsens Lung Injury in Experimental Canine Staphylococcus Aureus Pneumonia Inducing Septic Shock
9. In Canine Staphylococcus Aureus Pneumonia Circulating Granulocyte Counts Determine Survival and the Response to Donor Granulocyte Transfusion
10. The relevance of practice misalignments to trials in transfusion medicine
11. The effects of steroids during sepsis depend on dose and severity of illness: an updated meta-analysis
12. Human and Canine Septic Shock: Studies of Cardiovascular Abnormality, Mediators, and Therapies
13. Serial measures of total body oxygen consumption in an awake canine model of septic shock.
14. Risks of restrictive red blood cell transfusion strategies in patients with cardiovascular disease (CVD): a meta-analysis
15. Transfusion of recently donated (fresh) red blood cells (RBCs) does not improve survival in comparison with current practice, while safety of the oldest stored units is yet to be established: a meta-analysis
16. Information Assurance
17. Concerns over use of hydroxyethyl starch solutions
18. Reply to McGovern and Quintana
19. Excess Deaths Associated With Tigecycline After Approval Based on Noninferiority Trials
20. Tyrphostin AG 556 improves survival and reduces multiorgan failure in canine Escherichia coli peritonitis.
21. The anti-inflammatory approach to septic shock
22. Controlled trials of rG-CSF and CD11b-directed MAb during hyperoxia and E. coli pneumonia in rats
23. Continuous arteriovenous hemofiltration does not improve survival in a canine model of septic shock
24. Hemodynamic effects of dopamine, norepinephrine, and fluids in a dog model of sepsis
25. Role of endotoxemia in cardiovascular dysfunction and lethality: virulent and nonvirulent Escherichia coli challenges in a canine model of septic shock
26. 201 ANTICYTOKINE THERAPIES IN SEPTIC SHOCK
27. 199 NITRIC OXIDE IN SEPSIS
28. 202 THE NEUTROPHIL AS A THERAPEUTIC TARGET IN SEPTIC SHOCK
29. 200 SELECTED TREATMENT STRATEGIES FOR SEPTIC SHOCK BASED ON PROPOSED MECHANISMS OF PATHOGENESIS
30. Differential hemodynamic effects of L-NMMA in endotoxemic and normal dogs
31. Hemodynamic effects of dopamine, norepinephrine, and fluids in a dog model of sepsis
32. Cardiopulmonary effects of granulocyte colony-stimulating factor in a canine model of bacterial sepsis
33. Bacterial endotoxins and pathogenesis of Gram-negative infections: current status and future direction
34. Distinct Functional Activities in Canine Septic Shock of Monoclonal Antibodies Specific for the O Polysaccharide and Core Regions of Escherichia coli Lipopolysaccharide
35. The third component of complement protects against Escherichia coli endotoxin-induced shock and multiple organ failure.
36. PENTOXIFYLLINE CAN INCREASE TUMOR NECROSIS FACTOR LEVEL AND DECREASE SURVIVAL IN A CANINE MODEL OF GRAM-NEGATIVE SEPTIC SHOCK
37. THERAPEUTIC TRIAL OF RECONSTITUTED HUMAN HIGH DENSITY UPOPROTEIN IN A DOG MODEL OF GRAM-NEGATIVE SEPTIC SHOCK
38. LACK OF PROTECTION BY Nw-METHYL-L-ARGININE (NMA), A NITRIC OXIDE SYNTHASE INHIBITOR, IN ENDOTOXIN (LPS)-CHALLENGED CANINES
39. THE THIRD COMPONENT OF COMPLEMENT PROTECTS AGAINST ENDOTOXIN-INDUCED ORGAN DAMAGE
40. FENTANYL MAY DIRECTLY BLOCK CARDIAC B-AGONIST EFFECTS OF EPINEPHRINE IN DOGS
41. Plasma exchange does not improve survival in a canine model of human septic shock
42. Acute hemorrhage in dogs: construction and validation of models to quantify blood loss
43. N omega-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin.
44. Tumor necrosis factor challenges in canines: patterns of cardiovascular dysfunction
45. TNF but not IL-1 in dogs causes lethal lung injury and multiple organ dysfunction similar to human sepsis
46. Factors that determine the hemodynamic response to inhalation anesthetics
47. Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: a meta-analysis.
48. Risk of death does not alter the efficacy of hydrocortisone therapy in a mouse E. coli pneumonia model: risk and corticosteroids in sepsis.
49. Randomization in clinical trials of titrated therapies: unintended consequences of using fixed treatment protocols.
50. Preclinical trial of L-arginine monotherapy alone or with N-acetylcysteine in septic shock.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.